|
Clinical priority areas used to measure primary outcomes. |
|
| Clinical area |
Expected changes in intervention group |
|
|
|
| Asthma |
↓ short acting beta-agonists ↑ long-acting beta-agonists ↑ inhaled corticosteroids (decreased dose of steroids over time i.e. back titration or combinations of LABA & corticosteroids) |
| Depression |
↑ SSRIs, ↑ SNRIs ↓ TCAs; |
| Hypertension |
↑ diuretics ↓ other antihypertensives |
| Upper respiratory tract infection |
↓ antibiotics and ↑ appropriate antibiotics |
| Immunisation/vaccination |
Higher rate of immunization and closer compliance with schedule. |
| Lipid disorders |
↑ Statins, |
| Type 2 Diabetes |
↑ glitazones ↑ metformin ↑ insulin ↓ sulfonylureas |
| Non-inflamatory musculoskeletal including osteoarthritis |
↑ paracetamol ↓ NSAIDs ↓ Cox-2 inhibitors |
Coiera et al. BMC Medical Informatics and Decision Making 2006 6:33 doi:10.1186/1472-6947-6-33 |
|